BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 170 filers reported holding BIOLIFE SOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,098,696 | -38.1% | 79,558 | -0.9% | 0.00% | -100.0% |
| Q2 2023 | $1,773,878 | +107473.0% | 80,266 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $1,649 | +1.2% | 75,821 | -15.4% | 0.00% | 0.0% |
| Q4 2022 | $1,630 | -99.9% | 89,588 | -13.8% | 0.00% | 0.0% |
| Q3 2022 | $2,363,000 | +58.9% | 103,881 | -3.6% | 0.00% | 0.0% |
| Q2 2022 | $1,487,000 | -85.8% | 107,740 | -76.4% | 0.00% | -66.7% |
| Q1 2022 | $10,502,000 | -25.4% | 457,198 | +21.0% | 0.00% | -25.0% |
| Q4 2021 | $14,079,000 | +10.7% | 377,764 | +25.8% | 0.00% | 0.0% |
| Q3 2021 | $12,713,000 | -25.7% | 300,400 | -21.9% | 0.00% | -20.0% |
| Q2 2021 | $17,115,000 | +160.0% | 384,530 | +110.3% | 0.01% | +150.0% |
| Q1 2021 | $6,582,000 | +118.4% | 182,819 | +141.9% | 0.00% | +100.0% |
| Q4 2020 | $3,014,000 | +71.0% | 75,567 | +24.0% | 0.00% | 0.0% |
| Q3 2020 | $1,763,000 | +414.0% | 60,924 | +190.7% | 0.00% | – |
| Q2 2020 | $343,000 | – | 20,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |